IGC Pharma: Ascendiant Capital Raises Buy Rating, PT to $4.75.

martes, 9 de diciembre de 2025, 2:01 pm ET1 min de lectura
IGC--

IGC Pharma: Ascendiant Capital Raises Buy Rating, PT to $4.75.

IGC Pharma: Ascendiant Capital Raises Buy Rating, PT to $4.75.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios